Leukotriene E4 (LTE4) is a major leukotriene metabolite in urine. Urin
ary LTE4 concentration is often utilized as an index of total leukotri
ene synthesis. A novel method employing immunofiltration for the purif
ication of urinary LTE4 was developed. This immunofiltration method is
based upon the addition of excess anti-LTE4 antibody to urine which b
inds LTE4. Separation of bound LTE4 (high M-r) from high levels of unb
ound contaminants (low M-r) is then accomplished by filtration through
a 10,000 M-r cut-off filter. The LTE4-antibody complex is separated b
y precipitation of the antibody with methanol which is subsequently re
moved by centrifugation. Following evaporation of the methanol, enzyme
immunoassay is utilized for quantitation. This methodology was valida
ted by determining the recovery of tritiated and unlabeled LTE4 added
to urine and buffer and by comparison of results obtained with urine s
amples measured after HPLC purification (correlation r(2) = 0.72). Rep
roducibility of the assay was assessed by analyzing the same sample on
two different days (standard deviation of 18%). The mean urinary LTE4
levels in healthy subjects and asthmatics measured utilizing this met
hod were found to be identical to levels determined by HPLC/immunoassa
y. The ease and accuracy of this assay make it amenable for the analys
is of large numbers of samples. (C) 1997 Academic Press.